Olivier Lortholary

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

Dominique Salmon‐Céron, Florence Tubach, Olivier Lortholary et al. · Annals of the Rheumatic Diseases · 2010 · 283 citations

Medicine, Immunology, Pharmacotherapy +11

Human Listeriosis Caused by<i>Listeria ivanovii</i>

Christelle Guillet, Olivier Join‐Lambert, Alban Le Monnier et al. · Emerging infectious diseases · 2009 · 242 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +9

Efficacy of Rifampin-Moxifloxacin-Metronidazole Combination Therapy in Hidradenitis Suppurativa

Olivier Join‐Lambert, H. Coignard, Jean‐Philippe Jaïs et al. · Dermatology · 2010 · 152 citations

Pharmacy, Pharmacotherapy, Antimicrobial Pharmacology +6

Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns

Yoann Morice, Dominique Roulot, Véronique Grando et al. · Journal of General Virology · 2001 · 101 citations

Life Sciences, Infectious Diseases, Microbiology +17

Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS

Anne‐Sophie Brunel, Jacques Reynes, Édouard Tuaillon et al. · AIDS · 2012 · 70 citations

Pharmacy, Immunology, Infectious Diseases +17